A High Positive Lymph Node Ratio is Associated with Distant Recurrence after Surgical Resection of Ampullary Carcinoma

Journal of Gastrointestinal Surgery

Volumn 16, Issue 11, 2012, Pages 2056-2063

  Roland, Christina L ^a   Katz, Matthew H G ^a   Gonzalez, Graciela M N ^a   Pisters, Peter W T ^a   Vauthey, Jean Nicolas ^a   Wolff, Robert A ^a   Crane, Christopher H ^a   Lee, Jeffrey E ^a   Fleming, Jason B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Ampullary carcinoma; Lymph node ratio; Recurrence

Indexed keywords

EID: 84869135558     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-012-2015-2     Document Type: Article

References (36)

1. Narang, A. K., et al., Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital - Mayo Clinic collaborative study. Radiation oncology, 2011. 6(1): p. 126.
2. Todoroki, T., et al., Patterns and predictors of failure after curative resections of carcinoma of the ampulla of Vater. Annals of surgical oncology, 2003. 10(10): p. 1176-83.
3. Willett, C. G., et al., Patterns of failure after pancreaticoduodenectomy for ampullary carcinoma. Surgery, gynecology & obstetrics, 1993. 176(1): p. 33-8.
4. Woo, S. M., et al., Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma. Annals of surgical oncology, 2007. 14(11): p. 3195-201.
5. Kim, R. D., et al., Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma. Journal of the American College of Surgeons, 2006. 202(1): p. 112-9.
6. Iacono, C., et al., Adenocarcinoma of the ampulla of Vater: T-stage, chromosome 17p allelic loss, and extended pancreaticoduodenectomy are relevant prognostic factors. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract, 2007. 11(5): p. 578-88.
7. Hurtuk, M. G., et al., Does lymph node ratio impact survival in resected periampullary malignancies? American journal of surgery, 2009. 197(3): p. 348-52.
8. Lee, J. H., et al., Pattern analysis of lymph node metastasis and the prognostic importance of number of metastatic nodes in ampullary adenocarcinoma. The American surgeon, 2011. 77(3): p. 322-9.
9. Kim, W. S., et al., Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer. Journal of surgical oncology, 2012. 105(3): p. 266-72.
10. Ohike, N., et al., Tumor budding as a strong prognostic indicator in invasive ampullary adenocarcinomas. The American journal of surgical pathology, 2010. 34(10): p. 1417-24.
11. Sakata, J., et al., Assessment of the nodal status in ampullary carcinoma: the number of positive lymph nodes versus the lymph node ratio. World journal of surgery, 2011. 35(9): p. 2118-24.
12. Hsu, H. P., et al., Predictors of recurrence after pancreaticoduodenectomy in ampullary cancer: comparison between non-, early and late recurrence. Journal of the Formosan Medical Association = Taiwan yi zhi, 2007. 106(6): p. 432-43.
13. Hsu, H. P., et al., Loss of E-cadherin and beta-catenin is correlated with poor prognosis of ampullary neoplasms. Journal of surgical oncology, 2010. 101(5): p. 356-62.
14. Hsu, H. P., et al., Osteopontin-positive infiltrating tumor-associated macrophages in bulky ampullary cancer predict survival. Cancer biology & therapy, 2010. 10(2): p. 144-54.
15. Hsu, H. P., et al., Predictors for patterns of failure after pancreaticoduodenectomy in ampullary cancer. Annals of surgical oncology, 2007. 14(1): p. 50-60.
16. Beger, H. G., et al., Pathogenesis and treatment of neoplastic diseases of the papilla of Vater: Kausch-Whipple procedure with lymph node dissection in cancer of the papilla of Vater. Journal of hepato-biliary-pancreatic surgery, 2004. 11(4): p. 232-8.
17. Smith, R. A., et al., Preoperative CA19-9 levels and lymph node ratio are independent predictors of survival in patients with resected pancreatic ductal adenocarcinoma. Digestive surgery, 2008. 25(3): p. 226-32.
18. Bogoevski, D., et al., Nodal microinvolvement in patients with carcinoma of the papilla of vater receiving no adjuvant chemotherapy. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract, 2008. 12(11): p. 1830-7; discussion 1837-8.
19. Schumacher, P., et al., The metastatic lymph node ratio predicts survival in colon cancer. American journal of surgery, 2007. 194(6): p. 827-31; discussion 831-2.
20. Siewert, J. R., et al., Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Annals of surgery, 1998. 228(4): p. 449-61.
21. Tachibana, M., et al., Esophageal cancer with distant lymph node metastasis: prognostic significance of metastatic lymph node ratio. Journal of clinical gastroenterology, 2000. 31(4): p. 318-22.
22. Danko, M. E., et al., Improved staging in node-positive breast cancer patients using lymph node ratio: results in 1, 788 patients with long-term follow-up. Journal of the American College of Surgeons, 2010. 210(5): p. 797-805 e1, 805-7.
23. Riediger, H., et al., The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract, 2009. 13(7): p. 1337-44.
24. Pawlik, T. M., et al., Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery, 2007. 141(5): p. 610-8.
25. Bhatti, I., et al., Lymph node ratio versus number of affected lymph nodes as predictors of survival for resected pancreatic adenocarcinoma. World journal of surgery, 2010. 34(4): p. 768-75.
26. Bottger, T. C., et al., Clinicopathologic study for the assessment of resection for ampullary carcinoma. World journal of surgery, 1997. 21(4): p. 379-83.
27. Hwang, R. F., et al., Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer. Annals of surgical oncology, 2008. 15(5): p. 1356-66.
28. Yen, T. W., et al., Pancreaticoduodenectomy. Pancreatic Cancer, ed. D. D. Von Hoff, D. B. Evans, and R. H. Hruban2005, Sandury: Jones and Bartlett.
29. Katz, M. H., et al., Effect of neoadjuvant chemoradiation and surgical technique on recurrence of localized pancreatic cancer. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract, 2012. 16(1): p. 68-78; discussion 78-9.
30. Pisters, P. W., et al., Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive patients. Annals of surgery, 2001. 234(1): p. 47-55.
31. Edge, S. B., et al., AJCC Cancer Staging Manual2010, New York: Springer.
32. Albores-Saavedra, J., et al., Cancers of the ampulla of vater: demographics, morphology, and survival based on 5, 625 cases from the SEER program. Journal of surgical oncology, 2009. 100(7): p. 598-605.
33. Chan, C., et al., Clinical behavior and prognostic factors of periampullary adenocarcinoma. Annals of surgery, 1995. 222(5): p. 632-7.
34. Katz, M. H., et al., Non-pancreatic periampullary adenocarcinomas: an explanation for favorable prognosis. Hepato-gastroenterology, 2004. 51(57): p. 842-6.
35. Showalter, T. N., et al., The influence of prognostic factors and adjuvant chemoradiation on survival after pancreaticoduodenectomy for ampullary carcinoma. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract, 2011. 15(8): p. 1411-6.
36. Neoptolemos, J. P., et al., Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA: the journal of the American Medical Association, 2012. 308(2): p. 147-56.